InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Novak Rodger, Président. Insider active across 1 companies, notably CRISPR Therapeutics AG. Cumulatively, 6 reports have been logged. Total volume traded: €13.8m. The latest transaction was disclosed on 30 June 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€3m25,000 shares@ €139.16150.5% of flow
Common Shares
SEC:0001209191-21-044516·
€3m25,000 shares@ €139.1610.075% mcap25.3% of flow
Common Shares
SEC:0001209191-21-044516:0·
€3m25,000 shares@ €131.235947.7% of flow
Common Shares
SEC:0001209191-21-044012·
€3m25,000 shares@ €131.23590.070% mcap23.8% of flow
Common Shares
SEC:0001209191-21-044012:0·
€123,4451,171 shares@ €105.41811.8% of flow
Common Shares
SEC:0001209191-21-042811·
€123,4451,171 shares@ €105.41810.0026% mcap0.9% of flow
Common Shares
SEC:0001209191-21-042811:0·
6 of 6 declarations
About Novak Rodger
Rodger Novak is the President of CRISPR Therapeutics AG. In this role, he oversees strategic operations and ensures growth and innovation. CRISPR Therapeutics AG is a biotechnology company specializing in genome editing. Rodger plays a key role in developing the company's vision and objectives.
